Acute infection of some human leukemic cell lines with human immunodeficiency virus (HIV) generates a cytopathic infection which leaves behind a heterogeneous population of chronically infected survivors (5, 14, 17) . A number of cell lines have been derived from such chronically HIV-infected cells (7) ; a few of these have been found to have low basal expression of virus yet retain the ability to produce large quantities of infectious virus when stimulated (14, 16) . These cell lines have been studied extensively as in vitro models for cellular latency. U1 is one such cell line that was cloned from the chronically infected promonocytic leukemic cell line U937, and ACH-2 was similarly derived from the T-lymphocytic leukemic cell line A3.01. Studies of Ul and ACH-2 have provided substantial information about the stimuli and regulatory pathways that may be involved in the activation of HIV replication in vivo.
In both the Ul and ACH-2 cell lines, infectious virus production can be induced with phorbol ester or specific cytokines such as tumor necrosis factor alpha (15) (16) (17) 34 ). This activation results in a large induction of HIV mRNA, a process believed to involve, at least in part, the action of transcription factor NF-KB (10, 19) . Both cell lines have been found to express only low levels of predominantly multiply spliced HIV mRNA in the unstimulated state. Activated HIV gene expression results in an increase in the amounts of multiply spliced mRNA and the viral regulatory proteins which they encode (28, 33) , including Rev, whose function is critical for subsequent expression of unspliced and singly spliced mRNAs which encode HIV structural proteins (26, 27, 32) . In this regard, the Ul and ACH-2 resembles the events that follow integration during acute infection (22) .
Despite the increased understanding of the mechanisms involved in proviral activation in these latently infected lines, the underlying cause of their low basal HIV-specific transcription is not well understood. Because infectious virus can be obtained from both cell lines, it is unlikely that defective proviruses are the cause of low basal expression. Therefore, it is possible that their intracellular environments differ from the parental cell lines U937 and A3.01, such that viral replication cannot occur efficiently in the unstimulated state. Alternatively, low basal expression of the latent provirus could be due to a suboptimal site(s) of integration. Recently, the latter mechanism has been suggested for the ACH-2 cell line (41) .
To directly address these questions we have constructed a reporter HIV-1 with the Photinus pyralis luciferase gene (9) cloned in place of the nef gene and examined the ability of Ul, (23) and because it is known to be nonessential for in vitro infection (13, 40) . To overcome a possible block to HIV superinfection in these chronically infected cells, we used reporter virus pseudotyped with murine leukemia virus (MuLV) amphotropic envelope (24, 25) (Fig. 3) . Thus, the differential ability of antigen in nanograms. the reporter virus to spread in cell culture did not contribute to the observed differences in the luciferase expression between the latent lines and their parental lines. We have also found that the envelope-expressing luciferaserelative to U937 throughout the time course ( Fig. 2A) (Fig. 2B) . In contrast, when ACH-2 cells were (Fig. 4) comparable levels of luciferase DNA (Fig. 5, lanes 1 and 2) . ACH2 and A3.01 DNAs also had similar levels of luciferase DNA by the PCR assay (lanes 3 and 4). 
DISCUSSION
The UI and ACH-2 cell lines have provided useful models for investigating the mechanisms of proviral latency and activation. Our study has revealed that proviral latency in these two cell lines is controlled by different mechanisms. We found that the latently infected Ul cells failed to support efficient expression of a superinfected, luciferase-encoding HIV reporter, suggesting that it is the availability of necessary transacting factors in Ul cells which maintains proviral latency in these cells. U 1 cells may therefore lack some critical factor for viral expression or, alternatively, express a repressor of viral expression. In direct contrast, the ACH-2 cell line displayed no such intrinsic defect in supporting HIV replication. Rather, the ACH-2 cellular environment appeared to enhance the expression of the second virus, perhaps as a consequence of preexisting basal production of viral regulatory proteins or because of clonal variation. Proviral latency in ACH-2 cells may thus be categorized as a cis-acting effect, potentially a result of an unfavorable site of integration or hypermethylation (4) of the proviral DNA. This mode of latency in ACH-2 cells is also supported by a recent study by Winslow et al., who found high expression of a secondarily introduced provirus, but not of the endogenous one, in neomycin-selected ACH-2 cells following superinfection with a virus carrying a neomycin phosphotransferase gene (41) .
Early data showed that even in patients with AIDS, only a very small fraction of peripheral blood mononuclear cells produce significant levels of HIV mRNA (20) , a fraction believed to be significantly smaller than the number of DNApositive cells (38) . These findings were supported by subsequent studies which showed that a pool of latently infected cells does exist in infected patients (6, 37, 39) . In recent work with sensitive in situ PCR techniques capable of quantifying single-copy HIV-infected cells, a larger number of latently infected cells have been detected in both peripheral blood and the lymph nodes than was previously estimated (11, 12, 30 whether Ul and ACH-2 cells have direct in vivo counterparts, these cell lines pose interesting questions and should be useful models for the study of proviral regulation. Hence further investigation of the mechanisms of viral regulation in these models of cellular latency seems warranted.
Because of its potential to yield new insights into the cellular factors that regulate basal HIV expression, it is especially intriguing to speculate about the nature of the trans-acting defect found in the UI cells. The SpI-and NF-KB-binding sites have long been understood to be elements critical for HIV long terminal repeat activity (18, 21, 29) . Spl site-binding proteins are believed to be involved in the basal transcription of the HIV long terminal repeat; therefore one might speculate that differences in Spl site-binding proteins may be involved in the maintenance of proviral quiescence in the Ul cells. However, electrophoretic mobility shift assays with Spl site-containing probes and nuclear extracts from the Ul and U937 cells have not revealed any qualitative or quantitative differences in the protein complexes interacting with these sites (8) .
Activation of transcription in U1 cells has been correlated with an increase in NF-KB DNA-binding activity (19) . Chronic HIV infection of certain human myeloid/monocytic cell lines, including U937, has been found to induce increased nuclear NF-KB activity even in the absence of any exogenous regulatory stimuli (3, 35) . Interestingly, although Ul cells are derived from chronically infected U937 cells, their basal level of NF-KB activity does not appear to be upregulated, because they show only weak nuclear NF-KB-binding activity similar to that of uninfected, unstimulated U937 cells (8, 33) . Furthermore, PMA treatment of the HXB-Luc-superinfected Ul cells induced a 36-fold stimulation in the luciferase activity, whereas only a 2-fold stimulation was observed in the similarly infected U937 cells, suggesting that, in the latter, HIV infection may have already resulted in a near-maximal NF-KB induction. Thus, a lack of such HIV-induced NF-KB activity could be one mechanism which restricts the viral replication in Ul cells.
Although the trans-acting mechanism of latency in Ul cells may draw more experimental attention because of the interest in identifying the critical trans-acting factors necessary for HIV expression, it seems equally likely that the cis-acting effect found in ACH-2 cells could be used in cells in vivo. ACH-2 provides an interesting case in which cellular activation can overcome a cis-acting inhibitory effect and suggests that differences in the site of proviral integration can have a critical effect on the level of viral expression in the absence of activating stimuli. Such cis-acting mechanisms could be important in vivo where a suboptimal site of integration may limit viral expression to a level below a critical threshold level yet still permit viral upregulation by cellular activation.
In future studies, it will be interesting to test other latently infected cell lines to see whether the patterns revealed in U1 and ACH-2 may be generalized according to cell type. Additionally, characterization of other latently infected cell lines with trans-acting, Ul-like defects may eventually lead to the identification of new cellular factors that are critical for regulation of HIV gene expression.
